InnoCare Pharma Limited 09969.HK 價格預測與預測

Q: 技術分析指標如何適用於 09969.HK？

根據技術分析，InnoCare Pharma Limited 的綜合信號為 Buy。InnoCare Pharma Limited 有 3 個買入信號，2 個中性信號和 2 個賣出信號。

Q: 09969.HK 的費波那契回檔水準是多少？

InnoCare Pharma Limited 的費波那契回檔水準是 低於 100% 水準。

Q: InnoCare Pharma Limited 的 RSI 是多少？

InnoCare Pharma Limited 的 RSI 目前為 58.02，表明處於 中立 狀態

Q: InnoCare Pharma Limited 接下來 12 個月的價格是多少？

InnoCare Pharma Limited 09969.HK 接下來 12 個月的價格預估為 $0。

Q: InnoCare Pharma Limited 預計會漲到多高？

據華爾街分析師稱，InnoCare Pharma Limited 預計將達到 $0 的高預測值。

首頁

股票

09969.HK

預測

INNOCARE (09969.HK)

InnoCare Pharma Limited

HK$12.43

-2.12%

$-0.26

休市： Feb 16, 12:00:00 HKT

關鍵數據

前收市價

$12.66

開盤價

$12.7

當日範圍

$12.31 - $12.7

52週區間

$5.65 - $20.62

交易量

397.0K

平均成交量

6.8M

每股盈餘 (TTM)

-0.14

股息收益率

市值

$18.5B

什麼是 INNOCARE？

InnoCare Pharma Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Beijing, Beijing and currently employs 1,146 full-time employees. The company went IPO on 2020-03-23. InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The firm focuses on areas with unmet clinical needs, such as oncology and autoimmune diseases. The firm's primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat hematological tumors, solid tumors and autoimmune diseases. The firm is also developing products for the treatment of autoimmune diseases caused by abnormal T cell function. The firm conducts its businesses in domestic and overseas markets.

功能特性

資源

市場

09969.HK 股價預測摘要

09969.HK stock price ended at $12.66 on 星期五, after rising 0.48%

On the latest trading day Feb 13, 2026, the stock price of 09969.HK rose by 0.48%, climbing from $12.52 to $12.66. Throughout the session, the stock experienced a volatility of 2.42%, with prices fluctuating between a daily low of $12.42 and a high of $12.72. Alongside this price increase, trading volume also rose by 2.8M shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 2.9M shares were traded, amounting to a market value of approximately $18.9B.

09969.HK 技術面訊號

技術面訊號摘要

購買訊號 3

中性訊號 2

賣出訊號 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

09969.HK 目前顯示 3 個買入訊號與 2 個賣出訊號。該股票自 12:00 AM 以來一直處於上升趨勢狀態，在此期間價格總共變動了 0.48%。整體而言，技術指標顯示中期後市趨勢為 Buy。

09969.HK 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為09969.HK生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

技術分析指標如何適用於 09969.HK？



09969.HK 的費波那契回檔水準是多少？



InnoCare Pharma Limited 的 RSI 是多少？



InnoCare Pharma Limited 接下來 12 個月的價格是多少？



InnoCare Pharma Limited 預計會漲到多高？



InnoCare Pharma Limited（09969.HK）價格

09969.HK 股價走勢圖